MedPath
TGA Approval

NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule (236003)

236003

NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule

Juno Pharmaceuticals Pty Ltd

March 10, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/59e0f051b2b9f54222ded25404f599b7.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/930c321520acf72d0dfe795673c17845.pdf

Active Ingredients

naloxone hydrochloride dihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule (236003) - TGA 批准文号 | MedPath